Lexicon earns third $10M milestone from Novo Nordisk
Lexicon Pharmaceuticals says it earned a third $10 million milestone payment from Novo Nordisk after a key phase 1 development milestone for LX9851.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lexicon earns third $10 million Novo Nordisk milestone payment
Lexicon Pharmaceuticals says it earned a third $10 million milestone payment from Novo Nordisk after achieving a key Phase 1 development milestone for LX9851.